Metraipolis › archive › dc_25fc019dfef3

Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis — Europe PMC PMID:42819305

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42819305
DOI
10.3389/fmed.2026.1913582
License (as archived)
solo-consultazione
Archived
2026-10-08T14:19:10.155Z
SHA-256 of the archived text
1ce07921f0b6e45bc7ba2acde50643f48cdfab4e3665d23220097faf6e502141
Stable URL of this page
https://metraipolis.com/documento/dc_25fc019dfef3

How to cite

Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis — Europe PMC PMID:42819305 — Europe PMC (en), https://europepmc.org/article/MED/42819305 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25fc019dfef3 (Metraipolis archive dc_25fc019dfef3, sha256 1ce07921f0b6e45bc7ba2acde50643f48cdfab4e3665d23220097faf6e502141)
BibTeX
@misc{dc25fc019dfef3,
  title = {Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis — Europe PMC PMID:42819305},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42819305},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25fc019dfef3; sha256 1ce07921f0b6e45bc7ba2acde50643f48cdfab4e3665d23220097faf6e502141},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42819305. Agents can read the archived copy with the MCP tool read_document.